![]() |
Illustration of single-stranded RNA Illustration Credit: National Institute of General Medical Sciences |
New research pinpoints a gene that, when mutated, causes cancer through a mechanism scientists haven’t seen before: cells lose the ability to dispose of their trash, namely defective strands of RNA.
This mechanism appears to cut across many different malignancies and could present a whole new set of molecules for cancer drugs to target, as reported in the journal Science by a team from Harvard Medical School, Boston Children’s Hospital, and Dana-Farber Cancer Institute.
While studying zebrafish, Megan Insco, HMS instructor in medicine who was a research fellow in the lab of Leonard Zon at HMS and Boston Children’s at the time, identified a tumor-suppressing gene called CDK13. When mutated, it expedited the development of melanoma.
The same gene was also mutated in many human melanomas, she found.
But what was really surprising was how the CDK13 mutation causes cancer.
Investigating the RNAs made by melanoma cells, Insco saw multiple short, defective RNAs. She immediately shared this odd finding with Zon.